| __timestamp | BioMarin Pharmaceutical Inc. | Corcept Therapeutics Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 129764000 | 882000 |
| Thursday, January 1, 2015 | 152008000 | 1361000 |
| Friday, January 1, 2016 | 209620000 | 2058000 |
| Sunday, January 1, 2017 | 241786000 | 3554000 |
| Monday, January 1, 2018 | 315264000 | 5215000 |
| Tuesday, January 1, 2019 | 359466000 | 5504000 |
| Wednesday, January 1, 2020 | 524272000 | 5582000 |
| Friday, January 1, 2021 | 470515000 | 5281000 |
| Saturday, January 1, 2022 | 483669000 | 5385000 |
| Sunday, January 1, 2023 | 577065000 | 6481000 |
Unveiling the hidden dimensions of data
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. BioMarin Pharmaceutical Inc. and Corcept Therapeutics Incorporated, two prominent players, have shown distinct trends in their cost of revenue from 2014 to 2023. BioMarin's cost of revenue has surged by approximately 345%, reflecting its aggressive expansion and investment in research and development. In contrast, Corcept's cost of revenue has increased by about 635%, albeit from a much smaller base, indicating its strategic scaling efforts.
These trends underscore the dynamic nature of the pharmaceutical industry, where strategic investments in cost management can drive long-term success.
Cost of Revenue Comparison: Pfizer Inc. vs BioMarin Pharmaceutical Inc.
Cost of Revenue Comparison: Gilead Sciences, Inc. vs Corcept Therapeutics Incorporated
Comparing Cost of Revenue Efficiency: Zoetis Inc. vs Corcept Therapeutics Incorporated
Cost of Revenue: Key Insights for BeiGene, Ltd. and Corcept Therapeutics Incorporated
Cost of Revenue Trends: BioMarin Pharmaceutical Inc. vs Sarepta Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs Catalent, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Jazz Pharmaceuticals plc and Corcept Therapeutics Incorporated's Expenses
Cost Insights: Breaking Down Pharming Group N.V. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue: Key Insights for Lantheus Holdings, Inc. and Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated vs HUTCHMED (China) Limited: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Corcept Therapeutics Incorporated and Wave Life Sciences Ltd.
Cost Insights: Breaking Down Corcept Therapeutics Incorporated and Celldex Therapeutics, Inc.'s Expenses